Recurrence of extensive injection site reactions following DTPa or dTpa vaccine in children 4-6 years old

Vaccine

Volumn 29, Issue 25, 2011, Pages 4230-4237

  Quinn, Patrick ^a,b   Gold, Michael ^a,b   Royle, Jenny ^c   Buttery, Jim ^c,d   Richmond, Peter ^e   McIntyre, Peter ^f   Wood, Nick ^f   Lee, Su san ^a   Marshall, Helen ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adverse events; Diphtheria; Injection site reaction; Pertussis; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ANOREXIA; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DIPHTHERIA; DROWSINESS; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFECTION PREVENTION; INJECTION SITE PAIN; INJECTION SITE REACTION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; TETANUS; VACCINATION;

CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; RECURRENCE; SKIN DISEASES; VACCINATION;

EID: 79956199195     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.088     Document Type: Article

References (26)

1. Tinnion O.N., Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2000, (2):CD001478.
2. Centers for Disease and Control Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental Recommendations of the Advisory Committee on Immunisation Practices (ACIP). MMWR Recomm Rep 2000, 49(November (RR-13)):1-8.
3. Rennels M.B., Deloria M.A., Pichichero M.E., Losonsky G.A., Englund J.A., Meade B.D., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000, 105(e12):1-6.
4. Pichichero M.E., Edwards K.M., Anderson E.L., Rennels M.B., Englund J.A., Yerg D.E., et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four to six year old children. Pediatrics 2000, 105(1):1-8.
5. Marshall H., Nolan T., Roberton D., Richmond P., Lambert S., Jacquet J.M., et al. A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years. Vaccine 2006, 24:6120-6128.
6. Jacquet J.M., Bégué P., Grimprel E., Reinert P., Sandbu S., Silfverdal S.A., et al. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review. Vaccine 2006, 24(13):2440-2448.
7. Gold M.S., Noonan S., Osbourn M., Precepa S., Kempe A.E. Local reactions after fourth-dose of acellular pertussis vaccine in South Australia. MJA 2003, 179(4):191-194.
8. Pappenheimer A.M., Edsall G., Lawrence H.S., Banton H.J. A study of reactions following administration of crude and purified diphtheria toxoid in an adult population. Am J Hyg 1950, 52:353-370.
9. Scheifele D.W., Meekison W., Grace M., Barreto L., Carter A.O., Mitchell L., et al. Adverse reactions to the preschool (fifth) dose of absorbed diphtheria-pertussis-tetanus vaccine in Canadian children. Can Med Assoc J 1991, 145(6):641-647.
10. Halperin S.A., Scheifele D., Barreto L., Pim C., Guasparini R., Medd L., et al. Comparison of a fifth dose of a five-component acellular or whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J 1999, 18(9):772-779.
11. Woo E., Burwen D., Gatumu S., Ball R. Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system. Clin Infect Dis 2003, 37(3):351-358. Vaccine Adverse Event Reporting System Working Group.
12. Skowronski D.M., Remple V.P., Macnabb J., Pielak K., Patrick D.M., Halperin S.A., et al. Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity and anticipated impact. Pediatrics 2003, 112:e453-e459.
13. Adverse Drug Reactions Advisory Committee (ADRAC) Extensive limb swelling and DTPa booster doses. Aust Adverse Drug React Bull 2001, 20(August (3)).
14. Rennels M. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Semin Pediatr Infect Dis J 2003, 14(3):196-198.
15. Rennels M., Deloria M., Pichichero M., Englund J., Anderson E., Steinhoff M., et al. Lack of consistent relationship between quantity of aluminium in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 2002, 20:S44-S47.
16. Rowe J., Yerkovich S.T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., et al. Th2-associated local reactions to the acellular diphtheria tetanus pertussis vaccine in 4-6 year old children. Infect Immun 2005, 73(12):8130-8135.
17. Scheifele D.W., Halperin S.A., Ochnio J.J., Ferguson A.C., Skowronski D.M. A modified vaccine reduces the rate of large local injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine. Pediatr Infect Dis J 2005, 24:1059-1066.
18. Rennels M.B., Black S., Woo E.J., Campbell S., Edwards K. Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose. Pediatr Infect Dis J 2008, 27(5):464-465.
19. Kohl K., Walop W., Gidudu J., Ball L., Halperin S., Hammer S., et al. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007, 25:5858-5874.
20. Melville-Smith M.E., Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of enzyme-linked immunosorbent assay with the toxin neutralization test. J Med Microbiol 1988, 25:279-283.
21. Melville-Smith M.E., Seagroatt V.A., Watkins J.T. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983, 11:137-144.
22. Manclark C.R., Meade B.D., Burstyn D.G. Serological response to Bordatella pertussis. Manual of clinical laboratory immunology 1986, 388-394. American Society for Microbiology, Washington DC. 3rd ed. N.R. Rose, H. Friedmen, J.L. Fahey (Eds.).
23. National Health and Medical Research Council The Australian immunisation handbook 2000, Australian Government Publishing Service, Canberra. 7th ed.
24. National Health and Medical Research Council The Australian immunisation handbook 2003, Australian Government Publishing Service, Canberra. 8th ed.
25. Dagan R., Igbaria K., Piglansky L., Van Brusteghem F., Melot V., Kaufhold A. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7 year old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age. Vaccine 1999, 17(20-21):2620-2627.
26. Kosuwon P., Warachit B., Hutagalung Y., Borkird T., Kosalaraksa P., Bock H.L., et al. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year old children primed with four doses of whole-cell pertussis vaccine. Vaccine 2003, 21:4194-4200.